New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Prelude Therapeutics Incorporated (PRLD) vs Turn Therapeutics Inc. (TTRX)
- Prelude Therapeutics Incorporated PRLD 3.23 −0.92%
- Turn Therapeutics Inc. TTRX 8.10 −6.25%
Prelude Therapeutics Incorporated and Turn Therapeutics Inc. are both Biotechnology companies. Prelude Therapeutics Incorporated and Turn Therapeutics Inc. are of similar size ($264.2M and $260.5M). Across the 10 metrics below, Prelude Therapeutics Incorporated leads on 7 and Turn Therapeutics Inc. on 3.
Valuation
Profitability
| Metric | PRLD | TTRX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | — | 70.18% |
| Operating margin | (283.92%) | — | 0.00% |
| Net margin | (247.12%) | — | 0.00% |
| Free cash flow margin | (129.68%) | — | 0.00% |
| Return on equity | (58.36%) | (412.27%) | (51.58%) |
| Return on assets | (39.45%) | (123.72%) | (45.91%) |
| Return on invested capital | 0.00% | (291.26%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack